Childhood Anesthesia and Cognitive Function (UCSF-Anes-01)

December 11, 2013 updated by: University of California, San Francisco

Is Pediatric Anesthesia Associated With Long-term Hippocampal Dysfunction?

The purpose of this study is to determine whether pediatric anesthesia is associated with long-term hippocampal dysfunction

Study Overview

Status

Completed

Detailed Description

Contrary to a longstanding belief, anesthesia has lasting effects on the neonatal brain. In rats anesthesia causes death of brain cells, ill-timed conversion of stem cells to nerve cells and a certain kind of brain defect up to 8 months later. This brain defect is called a hippocampal deficit because it resembles the type of defect that people have when a structure in the brain called the hippocampus has been injured, removed or is no longer functioning. However, to date it is unknown if anesthesia given to human infants causes a lasting hippocampal deficit, which might manifest itself as memory problems and academic failure despite normal intelligence. The investigators will test the hypothesis that anesthesia for more than 2h given to children of less than 2 years of age without coexisting diseases of the brain or the heart causes long-term impairment of hippocampal function. Using state of the art hippocampal and general brain function testing the investigators will compare hippocampal dependent and hippocampal independent memory as well as general cognitive function and emotional state in 10 year-old children that underwent at least a 2h anesthetic at less than 2 years with that of a matched control group that did not undergo an anesthetic.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Davis, California, United States
        • University of Califoria, Davis
      • San Francisco, California, United States
        • Univeristy of California, San Francisco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children who received an anesthetic early in life

Description

Inclusion Criteria:

  • Anesthesia at less than 2 years of age
  • Anesthetic time greater than 2 hours
  • ASA I or II
  • Induction with Propofol or Sevoflurane +/- N2O
  • Maintenance with a volatile agent (sevoflurane, isoflurane, desflurane) +/- N2O

Exclusion Criteria:

  • Neurosurgery
  • Known genetic syndrome
  • Any other anesthetic agents (ketamine, meperidine, barbiturates, etomidate, methoxyflurane, methadone, lorazepam)
  • Low birthweight (<25%ile)
  • Gestational age , 36 weeks
  • color blindness
  • h/o CNS disease
  • cancer
  • head trauma
  • congenital heart disease
  • ASA III or IV
  • intra-operative hypotension (<30% baseline for > 5 min)
  • Bradycardia (<30% baseline for > 5 min)
  • Hypoxemia (Blood Oxygen Saturation <93% for > 5 min)
  • Hypercarbia (pCO2 > 60 mm Hg > 5 min)
  • Dysthermia (deviation from 36.5 deg C by > 1.5 deg C at any time)
  • Puberty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Treatment
Children who received an anesthetic prior to age 2
Control
Children who have never been anesthetized

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recollection
Time Frame: 6-12 years of age
Subjects who received and anesthetic during the first two years of life and controls are given a cognitive test at 6 to 12 years of age
6-12 years of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Familiarity, Child behavioral checklist
Time Frame: 6-12 years of age
cognitive testing
6-12 years of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Greg Stratmann, MD, PhD, University of California, San Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

May 20, 2011

First Submitted That Met QC Criteria

May 23, 2011

First Posted (Estimate)

May 24, 2011

Study Record Updates

Last Update Posted (Estimate)

December 12, 2013

Last Update Submitted That Met QC Criteria

December 11, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 10-01926

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Ability, General

Subscribe